alexa
Reach Us +1-947-333-4405
Role Of Pathology In The Era Of Precision Medicine | 28263
ISSN: 2161-0681

Journal of Clinical & Experimental Pathology
Open Access

Like us on:

Our Group organises 3000+ Global Conferenceseries Events every year across USA, Europe & Asia with support from 1000 more scientific Societies and Publishes 700+ Open Access Journals which contains over 50000 eminent personalities, reputed scientists as editorial board members.

Open Access Journals gaining more Readers and Citations
700 Journals and 15,000,000 Readers Each Journal is getting 25,000+ Readers

This Readership is 10 times more when compared to other Subscription Journals (Source: Google Analytics)

Role of pathology in the era of precision medicine

4th International Conference and Exhibition on Pathology

Dongfeng Tan

ScientificTracks Abstracts-Workshop: J Clin Exp Pathol

DOI: 10.4172/2161-0681.S1.016

Abstract
Presentation of advancements in precision medicine, outcome management and genetic classification require high-quality biospecimens. Some highlights of the presentation: ? Keep precious biological samples, including tissue and serum, safe and secure in our state of the art, CAP accredited and ISO certified facility ? Locate samples quickly and easily through our easy to access sample reporting and retrieval systems ? Improve research efficiency with comprehensive logistics management including collection, sample characterization, transportation, cryopreservation and storage ? Virtual biobanking
Biography
Dongfeng Tan received initial pathology training in China and Germany. After pathology residency at Yale University Medical Center (1994 to 1998), he completed an oncologic surgical pathology fellowship at Memorial Sloan-Kettering Cancer Center in New York. He joined Roswell Park Cancer Institute as an Assistant Professor of pathology in 1999. In 2004, He became an Associate Professor of Pathology at The University of Texas (UT) Health Science Center at Houston. He joined the faculty of The University of Texas MD Anderson Cancer Center in 2006 and was promoted to Professor in 2010. Currently, he is Professor of pathology and laboratory medicine, and medical oncology at MD Anderson Cancer Center. He has conducted independent and collaborative clinical and translational investigations and has been a principal investigator (PI) and Co-PI of funded research programs. These academic activities have led to 130 articles published.
Top